$HWH
HWH International Inc. Stock $hwh

$hwh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224019980 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue			$0.00
YoY Change
Cost Of Revenue	$170.0K	$122.8K	$334.8K
YoY Change	130.87%	57.92%
Gross Profit	$164.9K	$163.3K	$495.7K
YoY Change	35.64%	32.99%
Gross Profit Margin
Selling, General & Admin	$654.7K	$1.129M	$458.7K
YoY Change	176.26%	637.55%	32.0%
% of Gross Profit	397.02%	691.49%	92.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$15.57K	$14.64K	$58.01K
YoY Change	12.11%	0.36%
% of Gross Profit	9.44%	8.97%	11.7%
Operating Expenses	$654.7K	$1.495M	$458.7K
YoY Change	176.29%	876.77%	32.0%
Operating Profit	-$489.8K	-$1.332M	$36.99K
YoY Change	324.47%	4296.03%
Interest Expense	-$4.200K	$18.13K	$274.9K
YoY Change	-100.53%	-97.96%	-56.59%
% of Operating Profit			743.17%
Other Income/Expense, Net	$86.19K	-$4.433K	$187.3K
YoY Change	-89.04%	-100.5%
Pretax Income	-$403.6K	-$1.337M	-$183.8K
YoY Change	-173.43%	-281.58%	-164.31%
Income Tax			$47.20K
% Of Pretax Income
Net Earnings	-$387.9K	-$1.337M	-$231.0K
YoY Change	-198.2%	-338.34%	-333.59%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.08	-$0.05
COMMON SHARES
Basic Shares Outstanding	16.22M shares	16.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$821.4K	$974.6K	$586.0K
YoY Change	-32.68%	14.64%	-50.02%
Cash & Equivalents	$821.4K	$974.6K	$585.7K
Short-Term Investments
Other Short-Term Assets	$152.4K	$157.4K	$117.5K
YoY Change	190.32%	124.93%	1199.35%
Inventory	$1.460K	$3.598K	$1.977K
Prepaid Expenses	$14.92K	$15.78K	$106.9K
Receivables	$25.72K	$29.16K	$28.61K
Other Receivables	$107.0K	$59.21K	$41.20K
Total Short-Term Assets	$1.977M	$1.549M	$703.2K
YoY Change	55.35%	68.29%	-41.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$117.4K	$113.5K	$129.2K
YoY Change
Goodwill		$323.9K
YoY Change
Intangibles
YoY Change
Long-Term Investments	$14.01K		$21.25M
YoY Change	-99.93%		-75.88%
Other Assets	$389.9K	$436.7K	$298.3K
YoY Change
Total Long-Term Assets	$1.092M	$1.010M	$21.25M
YoY Change	-94.72%	-98.87%	-75.88%
TOTAL ASSETS
Total Short-Term Assets	$1.977M	$1.549M	$703.2K
Total Long-Term Assets	$1.092M	$1.010M	$21.25M
Total Assets	$3.068M	$2.558M	$21.96M
YoY Change	-86.02%	-97.15%	-75.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$525.6K	$602.6K	$632.0K
YoY Change	61.71%	40.03%	67.84%
Accrued Expenses	$462.7K	$444.0K	$514.9K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$241.3K	$279.8K	$205.0K
YoY Change	260.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.422M	$4.468M	$837.6K
YoY Change	1174.37%	938.27%	122.44%
LONG-TERM LIABILITIES
Long-Term Debt	$947.5K	$947.5K	$0.00
YoY Change
Other Long-Term Liabilities	$198.3K	$110.3K	$3.019M
YoY Change	-93.43%	-96.34%	0.01%
Total Long-Term Liabilities	$1.146M	$1.058M	$182.4K
YoY Change	-62.05%	-64.96%	-93.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.422M	$4.468M	$837.6K
Total Long-Term Liabilities	$1.146M	$1.058M	$182.4K
Total Liabilities	$6.568M	$5.526M	$3.856M
YoY Change	90.69%	60.22%	13.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.490M	-$4.102M	-$2.358M
YoY Change	186.2%	92.54%	16.0%
Common Stock	$1.623K	$1.623K	$1.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.612M	-$3.132M	-$2.358M
YoY Change
Total Liabilities & Shareholders Equity	$3.068M	$2.558M	$21.96M
YoY Change	-86.02%	-97.15%	-75.41%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$387.9K	-$1.337M	-$231.0K
YoY Change	-198.2%	-338.34%	-333.59%
Depreciation, Depletion And Amortization	$15.57K	$14.64K	$58.01K
YoY Change	12.11%	0.36%
Cash From Operating Activities	-$490.8K	-$638.2K	-$230.5K
YoY Change	2.3%	90.28%	-29.77%
INVESTING ACTIVITIES
Capital Expenditures	$25.95K	$2.072K	$14.57K
YoY Change		-74.81%
Acquisitions
YoY Change
Other Investing Activities	$20.83M	-$250.0K	$13.00K
YoY Change	-69.85%		-300.0%
Cash From Investing Activities	$20.81M	-$252.1K	$13.00K
YoY Change	-69.89%		-300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.49M	$749.9K	-9.100K
YoY Change	-69.98%	5668.83%
NET CHANGE
Cash From Operating Activities	-490.8K	-$638.2K	-230.5K
Cash From Investing Activities	20.81M	-$252.1K	13.00K
Cash From Financing Activities	-20.49M	$749.9K	-9.100K
Net Change In Cash	-175.9K	-$140.3K	-226.6K
YoY Change	-147.59%	-56.47%	-32.3%
FREE CASH FLOW
Cash From Operating Activities	-$490.8K	-$638.2K	-$230.5K
Capital Expenditures	$25.95K	$2.072K	$14.57K
Free Cash Flow	-$516.8K	-$640.3K	-$245.1K
YoY Change		86.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2024Q1	ACAX	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	ACAX	Impairment Of Convertible Note Receivable Related Party And Equity Method Investment Related Party ImpairmentOfConvertibleNoteReceivableRelatedPartyAndEquityMethodInvestmentRelatedParty		usd
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	ACAX	Impairment Of Convertible Note Receivable Related Party And Equity Method Investment Related Party ImpairmentOfConvertibleNoteReceivableRelatedPartyAndEquityMethodInvestmentRelatedParty		usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q1	ACAX	Convertible Notes Receivable Related Party ConvertibleNotesReceivableRelatedParty		usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023Q1	ACAX	Repayment Of Deferred Underwriting Compensation RepaymentOfDeferredUnderwritingCompensation		usd
CY2023Q1	ACAX	Issuance Of Common Stock To For Deferred Underwriting Compensation IssuanceOfCommonStockToForDeferredUnderwritingCompensation		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2023Q1	ACAX	Valuation Gain From Notes Receivable And Warrant Shrg ValuationGainFromNotesReceivableAndWarrantShrg		usd
CY2024Q1	ACAX	Initial Recognition Of Operating Lease Right Of Use Asset And Liability InitialRecognitionOfOperatingLeaseRightOfUseAssetAndLiability		usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q4	ACAX	Prepaid Sales Commision PrepaidSalesCommision		usd
CY2024Q1	ACAX	Increase Decrease In Prepaid Sales Commision IncreaseDecreaseInPrepaidSalesCommision		usd
CY2024Q1	ACAX	Prepaid Sales Commision PrepaidSalesCommision		usd
CY2023Q4	ACAX	Prepaid Sales Commision PrepaidSalesCommision		usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	974632	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	29156	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3598	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	59213	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	324521	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	141667	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15779	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1548566	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	113520	usd
CY2024Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	24874	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	21346768	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	411860	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	459339	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	598508	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1009593	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	22372830	usd
CY2024Q1	us-gaap	Assets Assets	2558159	usd
CY2023Q4	us-gaap	Assets Assets	23710684	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	602624	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	167355	usd
CY2024Q1	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	81634	usd
CY2023Q4	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	85206	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	362343	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	429687	usd
CY2023Q4	ACAX	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	3018750	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	279795	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4468314	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6024798	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110344	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182380	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	947500	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1057844	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	182380	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	20457011	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16223301	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16223301	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1623	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1078343	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-110223	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-197041	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4102241	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2765403	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-3132498	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2962171	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	164499	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	8666	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2967999	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2953505	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2558159	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23710684	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	286110	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	200562	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	122813	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	77769	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	163297	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	122793	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1129191	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	736391	usd
CY2024Q1	ACAX	Impairment Of Convertible Note Receivable Related Party And Equity Method Investment Related Party ImpairmentOfConvertibleNoteReceivableRelatedPartyAndEquityMethodInvestmentRelatedParty	366192	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1495383	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	736391	usd
CY2024Q1	us-gaap	Other Income OtherIncome	78013	usd
CY2023Q1	us-gaap	Other Income OtherIncome	999966	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18131	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	-49571	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	13853	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14744	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-53199	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4433	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	960620	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1336519	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	347022	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	175173	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1336519	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	171849	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	319	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	722	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1336838	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	171127	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	86818	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	58843	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	86818	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	58843	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1250020	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	229970	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1805434	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	171849	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	58843	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1574742	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2953505	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2953505	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1509390	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	25	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-645860	usd
CY2024Q1	ACAX	Adjustments To Additional Paid In Capital Revaluation For Sharing Services Global Corporation Note Receivable And Warrants AdjustmentsToAdditionalPaidInCapitalRevaluationForSharingServicesGlobalCorporationNoteReceivableAndWarrants	216188	usd
CY2024Q1	ACAX	Change In Noncontrolling Interest ChangeInNoncontrollingInterest	155514	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1336519	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86818	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2967999	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2967999	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1336519	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	171849	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	-49571	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	13853	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14744	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-53199	usd
CY2024Q1	us-gaap	Depreciation Depreciation	14643	usd
CY2023Q1	us-gaap	Depreciation Depreciation	14591	usd
CY2024Q1	ACAX	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	125143	usd
CY2023Q1	ACAX	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	130044	usd
CY2024Q1	ACAX	Impairment Of Convertible Note Receivable Related Party And Equity Method Investment Related Party ImpairmentOfConvertibleNoteReceivableRelatedPartyAndEquityMethodInvestmentRelatedParty	366192	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	19079	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-106723	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	83954	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-3692	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	111609	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-588	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1668	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	454	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	262732	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	194200	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-379	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-49835	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1	usd
CY2024Q1	ACAX	Increase Decrease In Value Added Tax Withheld IncreaseDecreaseInValueAddedTaxWithheld	3573	usd
CY2023Q1	ACAX	Increase Decrease In Value Added Tax Withheld IncreaseDecreaseInValueAddedTaxWithheld	-7983	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-20758	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-124210	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-125961	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-638210	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	262251	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2072	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8227	usd
CY2024Q1	ACAX	Convertible Notes Receivable Related Party ConvertibleNotesReceivableRelatedParty	-250000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-252072	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8227	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	26307	usd
CY2024Q1	ACAX	Repayment Of Deferred Underwriting Compensation RepaymentOfDeferredUnderwritingCompensation	325000	usd
CY2024Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1101255	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	182730	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	749948	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	182730	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-140334	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	436754	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-19361	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6558	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1159201	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	91178513	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	999506	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	91621825	usd
CY2024Q1	ACAX	Issuance Of Common Stock To For Deferred Underwriting Compensation IssuanceOfCommonStockToForDeferredUnderwritingCompensation	1509375	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	1359	usd
CY2024Q1	ACAX	Valuation Gain From Notes Receivable And Warrant Shrg ValuationGainFromNotesReceivableAndWarrantShrg	-216188	usd
CY2023Q1	ACAX	Initial Recognition Of Operating Lease Right Of Use Asset And Liability InitialRecognitionOfOperatingLeaseRightOfUseAssetAndLiability	46695	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zuijDFL8oSJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_827_zSiFb77JBOtk">DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HWH International Inc. (“HWH”) and its consolidated subsidiaries (collectively, the “Company”) operate a food and beverage (“F&B”) business in Singapore and South Korea. The Company operates a membership model in which individuals pay an upfront membership fee to become members. As members, these individuals receive discounted access to products and services offered by the Company’s affiliates. Previously, the Company had approximately 9,000 members, primarily in South Korea. Currently, this membership business has been temporarily suspended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HWH International Inc. was originally incorporated in Delaware on October 20, 2021 under the name Alset Capital Acquisition Corp. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company consummated the Business Combination on January 9, 2024 and changed its name from “Alset Capital Acquisition Corp.” to “HWH International Inc.” The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 9, 2022, the Company entered into an agreement and plan of merger (the “Merger Agreement”) by and among the Company, HWH International Inc., a Nevada corporation (the “HWH Nevada” or “Target”) and HWH Merger Sub Inc., a Nevada corporation and a wholly owned subsidiary of the Company (“Merger Sub”). The Company and Merger Sub are sometimes referred to collectively as the “ACAX Parties.” Pursuant to the Merger Agreement, a business combination between the Company and the Target was effected through the merger of Merger Sub with and into HWH Nevada, with the Target surviving the merger as a wholly owned subsidiary of the Company (the “Merger”). Upon the closing of the Merger (the “Closing”) on January 9, 2024, the Company changed its name to “HWH International Inc.” The board of directors of the Company (i) approved and declared advisable the Merger Agreement, the Ancillary Agreements (as defined in the Merger Agreement) and the transactions contemplated thereby and (ii) resolved to recommend approval of the Merger Agreement and related transactions by the stockholders of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Target was owned and controlled by certain member officers and directors of the Company and its sponsor. The Merger was consummated following the receipt of the required approval by the stockholders of the Company and the shareholders of the Target and the satisfaction of certain other customary closing conditions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total consideration paid at Closing (the “Merger Consideration”) by the Company to the Target’s shareholders was $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220909__20220909__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HWHInternationalIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztItWItPYVr3" title="Consideration paid value">125,000,000</span>, and was payable in shares of the common stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20220909__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HWHInternationalIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ9CEQLUHKKf" title="Common stock, par value">0.0001</span> per share, of the Company (“Company Common Stock”). The number of shares of the Company Common Stock paid to the shareholders of the Target as Merger Consideration was<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220909__20220909__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HWHInternationalIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3ShhMrMQj8c" title="Consideration paid shares"> 12,500,000</span>, with each share being valued at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220909__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--HWHInternationalIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJdEv6X0KXod" title="Shares issued price per share">10.00</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	more than 50% of the voting common stock
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	21000000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zuYLBFyeqS08" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zNtcFPwOrWDc">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Cash	999506	usd
CY2023Q4	us-gaap	Cash Cash	22505969	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	24874	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1162	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1162	usd
CY2022Q4	ACAX	Prepaid Sales Commision PrepaidSalesCommision	6839	usd
CY2023	ACAX	Increase Decrease In Prepaid Sales Commision IncreaseDecreaseInPrepaidSalesCommision	-6839	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	21198	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-21198	usd
CY2024Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	37311	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	37179	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	122813	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	77769	usd
CY2024Q1	ACAX	Commission Fee Percentage CommissionFeePercentage	0.25	pure
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	2242	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	4095	usd
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
CY2024Q1	us-gaap	Share Price SharePrice	10.00
CY2023Q2	us-gaap	Loans Payable LoansPayable	68928	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	909875	shares
CY2024Q1	us-gaap	Minority Interest MinorityInterest	164499	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	8666	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	8591072	shares
CY2022Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1972896	shares
CY2022Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	2156250	shares
CY2022Q3	us-gaap	Capital Units Outstanding CapitalUnitsOutstanding	476890	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	909875	shares
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	29156	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	28611	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	14302	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	9070	usd
CY2023Q3	us-gaap	Loans Payable LoansPayable	69158	usd
CY2024Q1	us-gaap	Loans Payable LoansPayable	205305	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	205305	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3598	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1977	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	113520	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	129230	usd
CY2024Q1	us-gaap	Depreciation Depreciation	14643	usd
CY2023Q1	us-gaap	Depreciation Depreciation	14591	usd
CY2024Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	0	usd
CY2022Q1	us-gaap	Cash Cash	183311	usd
CY2022Q1	us-gaap	Cash Cash	243567	sgd
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	466188	usd
CY2024Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	56000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M23D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2024Q1	us-gaap	Lease Cost LeaseCost	125143	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	130044	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	170801	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	144209	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3441	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12107	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	459339	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	598508	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	362343	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	429687	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110344	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182380	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	472687	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	612067	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	200562	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	374451	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	111616	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	486067	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13380	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	472687	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	362343	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110344	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	286110	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	200562	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	286110	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	621561	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	21989947	usd
CY2024Q1	us-gaap	Goodwill Goodwill	323864	usd
CY2023Q1	us-gaap	Goodwill Goodwill	0	usd
CY2024Q1	ACAX	Impairment Of Convertible Note Receivable And Investment In Associate Related Party ImpairmentOfConvertibleNoteReceivableAndInvestmentInAssociateRelatedParty	366192	usd

Files In Submission

Name	View Source	Status
0001493152-24-019980-index-headers.html	Edgar Link	pending
0001493152-24-019980-index.html	Edgar Link	pending
acax-20240331_cal.xml	Edgar Link	unprocessable
acax-20240331_pre.xml	Edgar Link	unprocessable
0001493152-24-019980.txt	Edgar Link	pending
0001493152-24-019980-xbrl.zip	Edgar Link	pending
acax-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
acax-20240331_def.xml	Edgar Link	unprocessable
acax-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HWH
HWH International Inc. Stock $hwh

2024 Q2 Form 10-Q Financial Statement

#000149315224019980 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HWH HWH International Inc. Stock $hwh

2024 Q2 Form 10-Q Financial Statement

#000149315224019980 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HWH
HWH International Inc. Stock $hwh